C07D 207 - Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom

Patents for C07D 207 - Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom (40,304)
12/2009
12/10/2009	WO2009112301A3 Polypeptide agents in the form of conjugates of keratin-binding polypeptides, polymers, and effector molecules, method for the production thereof, and use thereof
12/10/2009	WO2008148801A8 Disubstituted phenylpyrrolidines as modulators of cortical catecholaminergic neurotransmission
12/10/2009	US20090306407 Pyrrolidine analogue for preventing neurogenic pain and method for production thereof
12/10/2009	US20090306402 Composition of N-Alkenyl Carboxylic Acid Tertiary Amide
12/10/2009	US20090306396 Nitrogenated heterocyclic compound and pharmaceutical composition comprising the same
12/10/2009	US20090306371 Cyanopyrrole containing cyclic carbamate and thiocarbamate biaryls and methods for preparing the same
12/10/2009	US20090306175 Heterocyclic arylsulphones suitable for treating disorders that respond to modulation of the serotonin 5ht6 receptor
12/10/2009	US20090306174 Novel Five-Membered Iminocyclitol Derivatives as Selective and Potent Glycosidase Inhibitors: New Structures for Antivirals and Osteoarthritis Therapeutics
12/10/2009	US20090306173 Crystalline forms of atorvastatin magnesium
12/10/2009	US20090306156 Phosphodiesterase 4 inhibitors
12/10/2009	US20090306141 Novel Compounds
12/10/2009	US20090306138 chemokine receptor antagonists, such as 1-{3-[3-(4-fluorophenoxy)pyrrolidine-1-yl]propyl}-3-(3-methoxyphenyl)-urea, used as antiinflammatory agents
12/10/2009	US20090306134 Muscarinic receptor antagonists
12/10/2009	US20090306127 Certain Chemical Entities, Compositions and Methods
12/10/2009	US20090306109 Fungicide active substance combinations
12/10/2009	US20090306079 3,4-di-substituted cyclobutene-1,2-diones as cxc-chemokine receptor ligands
12/10/2009	US20090306077 Novel n- (2-aminophenyl) benzamide derivative having urea structure
12/10/2009	US20090306036 Methods of screening agents, conjugates or conjugate moieties for transport by a pept2 transporter
12/10/2009	US20090306022 7-substituted tetracycline compounds
12/10/2009	US20090305891 Cycloalkylphenyl substituted cyclic ketoenols
12/10/2009	CA2722723A1 4-(aminomethyl)cyclohexanamine derivatives as calcium channel blockers
12/09/2009	EP2130819A2 Crystalline forms of atorvastatin magnesium
12/09/2009	EP2129655A1 Prolinamide derivatives as modulators of voltage-gated sodium channels
12/09/2009	EP1409450B1 N-(3-amino-2-hydroxy-propyl) substituted alkylamide compounds
12/09/2009	EP1182183B1 Anthracene derivatives and organic electroluminescent devices made by using the same
12/09/2009	EP1020179B1 Peptide derivatives or pharmaceutically acceptable salts thereof, method for producing the same, use of said derivatives and pharmaceutical composition
12/09/2009	CN101600730A Methods, compounds, compositions and vehicles for delivering 3-amino-1-propanesulfonic acid
12/09/2009	CN101600689A Compounds and compositions as inhibitors of cannabinoid receptor 1 activity
12/09/2009	CN101600688A Atorvastatin strontium salt and pharmaceutical composition comprising same
12/09/2009	CN101597253A [N, N, O] and [O, N, O] type ligands, corresponding titanium complex containing same and application of titanium complex to ethylene polymerization catalysis
12/09/2009	CN101597252A Chiral dinaphthol radical pyrrole derivatives and preparation method and application thereof
12/09/2009	CN101597247A N-sulfinyl amino acid amide compound and application thereof
12/09/2009	CN100567298C Method for synthesizing polyhydroxy hyacinthacine alkaloid
12/09/2009	CN100567265C Organometallic complexes and organic electroluminescence device using the same
12/09/2009	CN100567242C Hsp90 family protein inhibitors
12/09/2009	CA2634513A1 Novel intermediate compounds and processes for their preparation
12/08/2009	US7629493 purifying the antiarrhythmia agent; by dissolving in water mixture which is saturated with at least one water-immiscible solvent and water-miscible solvents, to crystallize at a low temperature; produce on large industrial scales
12/08/2009	US7629474 cost effective way producing Levetiracetam; catalysis the amidation reaction from 5-hydroxy-4-n-propyl-furan-2-one intermediate
12/08/2009	US7629340 N-(6-membered aromatic ring)-amido anti-viral compounds
12/08/2009	CA2434829C New benzoylguanidine salt
12/08/2009	CA2398794C 1,3-disubstituted pyrrolidines as alpha-2-adrenoceptor antagonists
12/08/2009	CA2373183C Iminocyclitol inhibitors of hexoaminidase and glycosidase
12/03/2009	WO2009145286A1 Heterocyclic compound
12/03/2009	WO2009143767A1 Co-crystals of atorvastatin hemi-calcium and butanone, the preparation processes and uses as hmg-coa enzyme inhibitor thereof
12/03/2009	WO2009143630A1 Creatine sugar amides and salts thereof
12/03/2009	WO2009110002A4 Novel efflux pump inhibitors
12/03/2009	WO2009109539A3 2-cyanobenzensulfonamide derivatives having pesticidal properties
12/03/2009	WO2009103218A8 Ethylidene hydrazine carboxamide derivatives, preparation process and pharmaceutical use thereof
12/03/2009	US20090299078 Specifically tailored endohedral metallofullerenes
12/03/2009	US20090299036 Agent for preventing arteriosclerosis, agent for suppressing vascular intimal thickening and agent for improving vascular endothelial function
12/03/2009	US20090298905 Nitrogenatd trans-stilbene analogs, method for the obtention and medical applications thereof
12/03/2009	US20090298828 Alkoxyalkyl-Substituted Cyclic Keto-Enols
12/03/2009	US20090297473 Sulphonylpyrrole Hydrochloride Salts as Histone Deacetylases Inhibitors
12/03/2009	CA2725680A1 Heterocyclic compound
12/02/2009	EP2125870A1 Inhibitors of hepatitis c ns3 protease
12/02/2009	EP2125725A1 Compounds of formula (i) as serine protease inhibitors
12/02/2009	EP2125671A1 New products for the treatment of the iron chlorosis
12/02/2009	EP2124899A2 Stable pharmaceutical formulations of atorvastatin magnesium salt
12/02/2009	EP1861360B1 Pyrrolidine derivatives as histamine h3 receptor antagonists
12/02/2009	EP1606284B1 Compositions useful as protein kinase inhibitors
12/02/2009	EP1583742B1 Cb 1 receptour inverse agonists
12/02/2009	EP1434765B1 Substituted piperidines with selective binding to histamine h3-receptor
12/02/2009	EP1392683B1 Substituted 4h-chromenes and analogs as activators of caspases and inducers of apoptosis and their use as anticancer agents
12/02/2009	CN101595083A [F-18]-labeled l-glutamic acid, [F-18]-labeled l-glutamine, derivatives thereof and use thereof and processes for their preparation
12/02/2009	CN101591354A Functionalized ionic liquids, and methods of use thereof
12/02/2009	CN101591284A Method for preparing chlorfenapyr and analog thereof
12/02/2009	CN101591283A Preparation method of acetyl pyrrole using acetyl furan as raw material
12/02/2009	CN101591258A Chiral glutamate ionic liquid
12/02/2009	CN100564378C Pyrrolidine oxadiazole- and thiadiazole derivatives
12/02/2009	CN100564377C Substituted 4H-chromenes and analogs as activators of caspase and inducers of apoptosis and use thereof
12/02/2009	CN100564344C 2- and 2,5-substituted phenylketo-enols
12/02/2009	CN100563555C Magnetic resonance imaging device and RF receiving coil therefor
12/01/2009	US7626042 O-substituted hydroxyaryl derivatives
12/01/2009	US7625948 Ester that inhibits MTP in intestines as antilipemic agents for side effect reduction
12/01/2009	US7625944 carbamimidoyl benzylamide derivatives; preventing and treating the formation of thrombin during or after a PK dependent disease or condition after fibrinolysis treatment
12/01/2009	US7625941 N-substituted pyrrolidinone having a separated pendant ammonium cation by a variable length alkyl spacer and fluoroalkyl sulfonate anions; environmentally friendly solvent; catalysts for reactions, including nitration, acylation, esterification, etherification
12/01/2009	US7625932 Pyrrole and pyrazole derivatives as potentiators of glutamate receptors
12/01/2009	US7625929 Oxophenyl-cyclohexyl-propanolamine derivatives, production and use thereof in therapeutics
12/01/2009	CA2264556C Substituted n-[(aminoiminomethyl or aminomethyl)phenyl]propyl amides
11/2009
11/26/2009	WO2009142969A1 Therapeutic lactams
11/26/2009	WO2009141533A2 Pyrrole derivatives, preparation of same and therapeutic application thereof
11/26/2009	WO2009141532A2 Pyrrole derivatives, preparation of same and therapeutic application thereof
11/26/2009	WO2009141079A1 Novel [f-18]-labelled l-glutamic acid and l-glutamine derivatives (ii), use thereof and method for their production
11/26/2009	US20090292129 Process for resolving racemic mixtures and a diastereoisomeric complex of a resolving agent and an enantiomer of interest
11/26/2009	US20090292000 Pyrrolidine derivatives as prostaglandin modulators
11/26/2009	US20090291978 Enzyme Inhibitors
11/26/2009	US20090288707 Novel compounds for electronic material and organic electronic device using the same
11/26/2009	CA2724467A1 Therapeutic lactams
11/26/2009	CA2723459A1 Novel [f-18]-labelled l-glutamic acid and l-glutamine derivatives (ii), their use and processes for their preparation
11/25/2009	EP2123636A1 Method for producing aminoacetylpyrrolidinecarbonitrile derivative
11/25/2009	EP2123619A1 New [F-18]-marked L-glutamic acids and L-glutamic acid derivatives (II), application thereof and method for their manufacture
11/25/2009	EP2121599A2 Nitroxides for use in treating or preventing hypercholesterolemia
11/25/2009	EP2121596A1 Atorvastatin strontium salt and pharmaceutical composition comprising same
11/25/2009	EP2121595A1 Method for producing (meth)acrylic esters of n-hydroxyalkylated lactams
11/25/2009	EP2121594A1 Quaternary ammonium diphenylmethyl compounds useful as muscarinic receptor antagonists
11/25/2009	EP2121559A1 Catalytic method for producing (meth)acrylic acid esters of n-hydroxyalkylated lactams
11/25/2009	EP2120911A1 Amide and urea derivatives for the treatment of metabolic diseases
11/25/2009	EP2120575A1 Sphingosine-1 -phosphate receptor agonist and antagonist compounds
11/25/2009	EP1828172B1 Pyrrole derivatives having crth2 receptor antagonist activity
11/25/2009	EP0931060B1 Substituted n- (aminoiminomethyl or aminomethyl)phenyl propyl amides

1 ... 69 70 71 72 73 74 75 76 77 78 79 80 81 82 83 84 85 86 87 88 89 ... 404